Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 26,084 shares of the company's stock, valued at approximately $1,927,000.
Several other institutional investors have also added to or reduced their stakes in RYAN. GAMMA Investing LLC grew its position in Ryan Specialty by 21.8% during the first quarter. GAMMA Investing LLC now owns 2,101 shares of the company's stock valued at $155,000 after acquiring an additional 376 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Ryan Specialty by 3.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,215 shares of the company's stock valued at $902,000 after purchasing an additional 460 shares during the period. Wealth Alliance LLC purchased a new stake in shares of Ryan Specialty during the first quarter valued at approximately $303,000. Sumitomo Life Insurance Co. purchased a new stake in shares of Ryan Specialty during the first quarter valued at approximately $1,056,000. Finally, Wellington Management Group LLP purchased a new stake in shares of Ryan Specialty during the fourth quarter valued at approximately $29,599,000. 84.82% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Ryan Specialty
In other news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the transaction, the executive vice president owned 1,117 shares of the company's stock, valued at approximately $73,543.28. The trade was a 92.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director David P. Bolger sold 5,000 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the transaction, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their position. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.
Ryan Specialty Price Performance
NYSE RYAN traded down $3.22 during trading hours on Friday, reaching $57.97. The company's stock had a trading volume of 4,994,985 shares, compared to its average volume of 1,086,969. The firm's 50-day moving average price is $66.47 and its 200-day moving average price is $68.20. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45. Ryan Specialty Holdings Inc. has a 1 year low of $55.77 and a 1 year high of $77.16. The company has a market capitalization of $15.21 billion, a price-to-earnings ratio of 165.63, a PEG ratio of 1.65 and a beta of 0.64.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.66 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.66. Ryan Specialty had a return on equity of 49.78% and a net margin of 6.81%. The business had revenue of $855.17 million for the quarter, compared to the consensus estimate of $837.52 million. During the same quarter in the previous year, the company posted $0.58 EPS. The company's revenue was up 23.0% compared to the same quarter last year. On average, equities research analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Stockholders of record on Tuesday, August 12th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, August 12th. This represents a $0.48 annualized dividend and a dividend yield of 0.8%. Ryan Specialty's payout ratio is currently 137.14%.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the company. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and raised their price target for the stock from $74.00 to $81.00 in a research note on Tuesday, May 13th. Morgan Stanley dropped their price target on Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating for the company in a research note on Monday, July 14th. TD Cowen began coverage on Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price objective for the company. Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Barclays decreased their price objective on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating for the company in a report on Monday, July 7th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $75.73.
Get Our Latest Analysis on Ryan Specialty
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.